Tandem Diabetes Care/TNDM

$31.95

0.63%
-
1D1W1MYTD1YMAX

About Tandem Diabetes Care

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

Ticker

TNDM

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

John Sheridan

Employees

2,400

Headquarters

San diego, United States

TNDM Metrics

BasicAdvanced
$2.09B
Market cap
-
P/E ratio
-$3.44
EPS
1.15
Beta
-
Dividend rate
$2.09B
1.14601
$42.09
$13.82
1.8M
3.831
3.022
90.882
90.882
-22.2%
-59.08%
-27.07%
2.797
6.659
6.727
-6.68%
-133.12%
14.44%

What the Analysts think about TNDM

Analyst Ratings

Majority rating from 17 analysts.
Buy

Price Targets

Average projection from 14 analysts.
12.46% upside
High $60.00
Low $18.00
$31.95
Current price
$35.93
Average price target

TNDM Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-15.25% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$196.7M
5.98%
Net income
$-30M
-8.81%
Profit margin
-15.25%
-13.94%

TNDM Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 6.01%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.63
-$0.30
-$0.38
-$0.27
-
Expected
-$0.52
-$0.53
-$0.34
-$0.25
-$0.76
Surprise
21.94%
-43.6%
13.02%
6.01%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Tandem Diabetes Care stock?

Tandem Diabetes Care (TNDM) has a market cap of $2.09B as of April 19, 2024.

What is the P/E ratio for Tandem Diabetes Care stock?

The price to earnings (P/E) ratio for Tandem Diabetes Care (TNDM) stock is 0 as of April 19, 2024.

Does Tandem Diabetes Care stock pay dividends?

No, Tandem Diabetes Care (TNDM) stock does not pay dividends to its shareholders as of April 19, 2024.

When is the next Tandem Diabetes Care dividend payment date?

Tandem Diabetes Care (TNDM) stock does not pay dividends to its shareholders.

What is the beta indicator for Tandem Diabetes Care?

Tandem Diabetes Care (TNDM) has a beta rating of 1.15. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Tandem Diabetes Care stock price target?

The target price for Tandem Diabetes Care (TNDM) stock is $35.93, which is 16.17% above the current price of $30.93. This is an average based on projections from 14 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Tandem Diabetes Care stock

Buy or sell Tandem Diabetes Care stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing